Cargando…

Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment

In efforts to overcome current challenges in cancer treatment, multifunctional nanoparticles are attracting growing interest, including nanoparticles made with polydopamine (PDA). PDA is a nature-inspired polymer with a dark brown color. It has excellent biocompatibility and is biodegradable, offeri...

Descripción completa

Detalles Bibliográficos
Autores principales: Acter, Shahinur, Moreau, Michele, Ivkov, Robert, Viswanathan, Akila, Ngwa, Wilfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223368/
https://www.ncbi.nlm.nih.gov/pubmed/37242072
http://dx.doi.org/10.3390/nano13101656
_version_ 1785049925074026496
author Acter, Shahinur
Moreau, Michele
Ivkov, Robert
Viswanathan, Akila
Ngwa, Wilfred
author_facet Acter, Shahinur
Moreau, Michele
Ivkov, Robert
Viswanathan, Akila
Ngwa, Wilfred
author_sort Acter, Shahinur
collection PubMed
description In efforts to overcome current challenges in cancer treatment, multifunctional nanoparticles are attracting growing interest, including nanoparticles made with polydopamine (PDA). PDA is a nature-inspired polymer with a dark brown color. It has excellent biocompatibility and is biodegradable, offering a range of extraordinary inherent advantages. These include excellent drug loading capability, photothermal conversion efficiency, and adhesive properties. Though the mechanism of dopamine polymerization remains unclear, PDA has demonstrated exceptional flexibility in engineering desired morphology and size, easy and straightforward functionalization, etc. Moreover, it offers enormous potential for designing multifunctional nanomaterials for innovative approaches in cancer treatment. The aim of this work is to review studies on PDA, where the potential to develop multifunctional nanomaterials with applications in photothermal therapy has been demonstrated. Future prospects of PDA for developing applications in enhancing radiotherapy and/or immunotherapy, including for image-guided drug delivery to boost therapeutic efficacy and minimal side effects, are presented.
format Online
Article
Text
id pubmed-10223368
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102233682023-05-28 Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment Acter, Shahinur Moreau, Michele Ivkov, Robert Viswanathan, Akila Ngwa, Wilfred Nanomaterials (Basel) Review In efforts to overcome current challenges in cancer treatment, multifunctional nanoparticles are attracting growing interest, including nanoparticles made with polydopamine (PDA). PDA is a nature-inspired polymer with a dark brown color. It has excellent biocompatibility and is biodegradable, offering a range of extraordinary inherent advantages. These include excellent drug loading capability, photothermal conversion efficiency, and adhesive properties. Though the mechanism of dopamine polymerization remains unclear, PDA has demonstrated exceptional flexibility in engineering desired morphology and size, easy and straightforward functionalization, etc. Moreover, it offers enormous potential for designing multifunctional nanomaterials for innovative approaches in cancer treatment. The aim of this work is to review studies on PDA, where the potential to develop multifunctional nanomaterials with applications in photothermal therapy has been demonstrated. Future prospects of PDA for developing applications in enhancing radiotherapy and/or immunotherapy, including for image-guided drug delivery to boost therapeutic efficacy and minimal side effects, are presented. MDPI 2023-05-17 /pmc/articles/PMC10223368/ /pubmed/37242072 http://dx.doi.org/10.3390/nano13101656 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Acter, Shahinur
Moreau, Michele
Ivkov, Robert
Viswanathan, Akila
Ngwa, Wilfred
Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment
title Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment
title_full Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment
title_fullStr Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment
title_full_unstemmed Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment
title_short Polydopamine Nanomaterials for Overcoming Current Challenges in Cancer Treatment
title_sort polydopamine nanomaterials for overcoming current challenges in cancer treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223368/
https://www.ncbi.nlm.nih.gov/pubmed/37242072
http://dx.doi.org/10.3390/nano13101656
work_keys_str_mv AT actershahinur polydopaminenanomaterialsforovercomingcurrentchallengesincancertreatment
AT moreaumichele polydopaminenanomaterialsforovercomingcurrentchallengesincancertreatment
AT ivkovrobert polydopaminenanomaterialsforovercomingcurrentchallengesincancertreatment
AT viswanathanakila polydopaminenanomaterialsforovercomingcurrentchallengesincancertreatment
AT ngwawilfred polydopaminenanomaterialsforovercomingcurrentchallengesincancertreatment